Ligand validation:7EXO

MPD: (4S)-2-METHYL-2,4-PENTANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7EXO_MPD_A_901	42%	82%	0.134	0.853	0.26	0.53	-	-	2	0	100%	1
7EXO_MPD_A_904	9%	64%	0.295	0.779	0.27	1.1	-	1	6	0	100%	1
7ELV_MPD_E_901	34%	89%	0.147	0.828	0.31	0.34	-	-	2	0	100%	1
9D77_MPD_A_505	100%	87%	0.032	0.998	0.16	0.52	-	-	1	0	100%	1
9H8Q_MPD_B_602	100%	82%	0.039	0.988	0.35	0.44	-	-	3	0	100%	1
9I7H_MPD_B_101	100%	69%	0.041	0.987	0.27	0.92	-	-	3	0	100%	1
9MMI_MPD_B_301	100%	79%	0.04	0.983	0.3	0.56	-	-	4	0	100%	1
2BJK_MPD_A_1520	99%	68%	0.046	0.985	0.64	0.58	-	-	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.